These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
487 related articles for article (PubMed ID: 12816990)
1. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice. Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990 [TBL] [Abstract][Full Text] [Related]
2. Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice. Link JM; Rich CM; Korat M; Burrows GG; Offner H; Vandenbark AA Clin Immunol; 2007 Apr; 123(1):95-104. PubMed ID: 17257899 [TBL] [Abstract][Full Text] [Related]
3. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch. Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073 [TBL] [Abstract][Full Text] [Related]
4. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice. Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213 [TBL] [Abstract][Full Text] [Related]
5. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice. Rich C; Link JM; Zamora A; Jacobsen H; Meza-Romero R; Offner H; Jones R; Burrows GG; Fugger L; Vandenbark AA Eur J Immunol; 2004 May; 34(5):1251-61. PubMed ID: 15114658 [TBL] [Abstract][Full Text] [Related]
6. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. Oliver AR; Lyon GM; Ruddle NH J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031 [TBL] [Abstract][Full Text] [Related]
7. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578 [TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115 [TBL] [Abstract][Full Text] [Related]
9. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. Mars LT; Bauer J; Gross DA; Bucciarelli F; Firat H; Hudrisier D; Lemonnier F; Kosmatopoulos K; Liblau RS J Immunol; 2007 Oct; 179(8):5090-8. PubMed ID: 17911594 [TBL] [Abstract][Full Text] [Related]
10. TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes. Dahan R; Tabul M; Chou YK; Meza-Romero R; Andrew S; Ferro AJ; Burrows GG; Offner H; Vandenbark AA; Reiter Y Eur J Immunol; 2011 May; 41(5):1465-79. PubMed ID: 21469129 [TBL] [Abstract][Full Text] [Related]
11. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515 [TBL] [Abstract][Full Text] [Related]
12. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice. Kort JJ; Kawamura K; Fugger L; Weissert R; Forsthuber TG J Neuroimmunol; 2006 Apr; 173(1-2):23-34. PubMed ID: 16386804 [TBL] [Abstract][Full Text] [Related]
13. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response. Lobell A; Weissert R; Eltayeb S; de Graaf KL; Wefer J; Storch MK; Lassmann H; Wigzell H; Olsson T J Immunol; 2003 Feb; 170(4):1806-13. PubMed ID: 12574345 [TBL] [Abstract][Full Text] [Related]
14. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein. Mendel I; Natarajan K; Ben-Nun A; Shevach EM J Neuroimmunol; 2004 Apr; 149(1-2):10-21. PubMed ID: 15020060 [TBL] [Abstract][Full Text] [Related]
15. Transfer of severe experimental autoimmune encephalomyelitis by IL-12- and IL-18-potentiated T cells is estrogen sensitive. Ito A; Matejuk A; Hopke C; Drought H; Dwyer J; Zamora A; Subramanian S; Vandenbark AA; Offner H J Immunol; 2003 May; 170(9):4802-9. PubMed ID: 12707362 [TBL] [Abstract][Full Text] [Related]
16. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534 [TBL] [Abstract][Full Text] [Related]
17. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Lyons JA; Ramsbottom MJ; Cross AH Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610 [TBL] [Abstract][Full Text] [Related]
19. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Mendel I; Kerlero de Rosbo N; Ben-Nun A Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871 [TBL] [Abstract][Full Text] [Related]
20. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions. Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L Front Immunol; 2020; 11():575451. PubMed ID: 33329540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]